Skip to main content
Premium Trial:

Request an Annual Quote

GeneGo to Market Omicsoft’s Array Software

NEW YORK (GenomeWeb News) – GeneGo said today that it will sell Omicsoft’s array software as a bundled offering with its data mining suites.

The agreement covers Omicsoft’s Array Studio software and its Array Server solution, which will be marketed along with GeneGo’s Metacore and Metadrug suites. GeneGo will market these products on a global basis, excluding Japan.

The Array Studio software provides statistical and visualization analysis, and the Array Server allows users to store, share, search, and integrate microarray, SNP, and CNV data.

The partnership will allow Omicsoft to “continue to focus on new technology developments, including next generation sequencing enterprise solutions,” Omicsoft President Jack Liu said in a statement.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.